{"organizations": [], "uuid": "708de0edb26e7030aeaa7dc92695923838c69441", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-ferring-says-specific-financial-de/brief-ferring-says-specific-financial-details-of-transaction-with-ligand-pharma-are-not-disclosed-idUSASM000ICR", "country": "US", "domain_rank": 408, "title": "BRIEF-Ferring Says Specific Financial Details Of Transaction With Ligand Pharma Are Not Disclosed​", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-22T16:55:00.000+02:00", "replies_count": 0, "uuid": "708de0edb26e7030aeaa7dc92695923838c69441"}, "author": "", "url": "https://www.reuters.com/article/brief-ferring-says-specific-financial-de/brief-ferring-says-specific-financial-details-of-transaction-with-ligand-pharma-are-not-disclosed-idUSASM000ICR", "ord_in_thread": 0, "title": "BRIEF-Ferring Says Specific Financial Details Of Transaction With Ligand Pharma Are Not Disclosed​", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "specific financial details of transaction with ligand pharma", "sentiment": "negative"}, {"name": "ligand pharma", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "ligand", "sentiment": "none"}, {"name": "ligand pharma", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 22, 2018 / 2:56 PM / Updated 12 minutes ago BRIEF-Ferring Says Specific Financial Details Of Transaction With Ligand Pharma Are Not Disclosed​ Reuters Staff \nJan 22 (Reuters) - ‍Ferring Pharmaceuticals: \n* FERRING ENTERS INTO WORLDWIDE OMNIAB® PLATFORM LICENSE AGREEMENT WITH LIGAND \n* ‍FERRING PHARMACEUTICALS SAYS SPECIFIC FINANCIAL DETAILS OF TRANSACTION WITH LIGAND PHARMA ARE NOT DISCLOSED​ Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-22T16:55:00.000+02:00", "crawled": "2018-01-22T17:14:52.010+02:00", "highlightTitle": ""}